Most recent explorations of the functional role of CD271 in melanoma have clearly demonstrated that CD271+ cells comprise a special subtype of melanoma cells with stem-like properties and a lower expression of melanocyte-markers such as MART1, MITF and tyrosinase [86, 87]. This evidence concerns the gene MITF and melanoma.